LI-CYCLE HOLDINGS CORP (LICY)

CA50202P1053 - Common Stock

0.7053  +0.04 (+6%)

After market: 0.7047 0 (-0.09%)

Buy % Consensus

49

ChartMill assigns a Buy % Consensus number of 49% to LICY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 2.18. This target is 209.49% above the current price.
LICY was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about LICY.
In the previous month the buy percentage consensus was at a similar level.
LICY was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.710.761.022.187.35 - 7.40% 44.62% 209.49% 942.11%
Up and Down Grades
Date Firm Action Rating
2024-04-19 Chardan Capital Maintains Neutral -> Neutral
2023-11-16 Chardan Capital Downgrade Buy -> Neutral
2023-11-16 UBS Downgrade Buy -> Neutral
2023-11-16 Morgan Stanley Maintains Underweight -> Underweight
2023-10-23 TD Cowen Downgrade Outperform -> Market Perform
2023-08-16 Chardan Capital Maintains Buy -> Buy
2023-08-15 Wedbush Reiterate Outperform -> Outperform
2023-08-01 Chardan Capital Reiterate Buy -> Buy
2023-06-26 Piper Sandler Maintains Overweight -> Overweight
2023-05-16 Chardan Capital Reiterate Buy -> Buy
2023-05-04 Cantor Fitzgerald Initiate Buy
2023-05-03 Chardan Capital Maintains Buy
2023-03-31 TD Securities Maintains Outperform
2023-03-31 Baird Maintains Neutral
2023-02-28 Chardan Capital Reiterate Buy
2023-02-01 Citigroup Maintains Buy
2023-01-31 Chardan Capital Maintains Buy
2023-01-31 Baird Maintains Neutral
2023-01-25 Morgan Stanley Downgrade Equal-Weight -> Underweight
2022-12-15 Citigroup Maintains Buy
2022-09-30 Morgan Stanley Maintains Equal-Weight
2022-09-15 Chardan Capital Maintains Buy
2022-09-15 BMO Capital Maintains Outperform
2022-09-15 Baird Maintains Neutral
2022-06-15 Cowen & Co. Maintains Outperform
2022-06-15 Baird Maintains Neutral
2022-06-03 Morgan Stanley Maintains Equal-Weight
2022-04-07 Citigroup Maintains Buy
2022-02-10 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-01-13 Chardan Capital Maintains Buy